Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
Patrangsit Healthcare Group PCLBKK:PHG +1.98%43 Altman Z-Score is 6.62 as of Jul. 16, 2026, which is 27% below its 10-year median of 9.09. GuruFocus rates BKK:PHG with a GF Score™ of 43/100 and a GF Value™ of ฿15.89 (Significantly Undervalued). Among 659 Healthcare Providers & Services companies, Patrangsit Healthcare Group PCL ranks better than 82.25% on this metric.
The Altman Z-Score is a model designed to predict the likelihood of a company going bankrupt within the next two years. Created by American finance professor Edward Altman in 1968, the model is specifically designed for publicly traded manufacturing companies with assets greater than $1 million.
Good Sign:
Altman Z-score of 6.62 is strong.
Patrangsit Healthcare Group PCL has a Altman Z-Score of 6.62, indicating it is in Safe Zones. This implies the Altman Z-Score is strong.
The zones of discrimination were as such:
When Altman Z-Score <= 1.8, it is in Distress Zones.
When Altman Z-Score >= 3, it is in Safe Zones.
When Altman Z-Score is between 1.8 and 3, it is in Grey Zones.
The historical rank and industry rank for Patrangsit Healthcare Group PCL's Altman Z-Score or its related term are showing as below:
BKK:PHG'
s Altman Z-Score Range Over the Past 10 Years
Min: 6.62 Med: 9.09 Max: 10.92
Current: 6.62
During the past 5 years, Patrangsit Healthcare Group PCL's highest Altman Z-Score was 10.92. The lowest was 6.62. And the median was 9.09.
Patrangsit Healthcare Group PCL (BKK:PHG) Altman Z-Score Explanation
X1: The Working Capital/Total Assets (WC/TA) ratio is a measure of the net liquid assets of the firm relative to the total capitalization. Working capital is defined as the difference between current assets and current liabilities. Ordinarily, a firm experiencing consistent operating losses will have shrinking current assets in relation to total assets. Altman found this one proved to be the most valuable liquidity ratio comparing with the current ratio and the quick ratio. This is however the least significant of the five factors.
X2: Retained Earnings/Total Assets: the RE/TA ratio measures the leverage of a firm. Retained earnings is the account which reports the total amount of reinvested earnings and/or losses of a firm over its entire life. Those firms with high RE, relative to TA, have financed their assets through retention of profits and have not utilized as much debt.
X3, Earnings Before Interest and Taxes/Total Assets (EBIT/TA): This ratio is a measure of the true productivity of the firm's assets, independent of any tax or leverage factors. Since a firm's ultimate existence is based on the earning power of its assets, this ratio appears to be particularly appropriate for studies dealing with corporate failure. This ratio continually outperforms other profitability measures, including cash flow.
X4, Market Value of Equity/Book Value of Total Liabilities (MVE/TL): The measure shows how much the firm's assets can decline in value (measured by market value of equity plus debt) before the liabilities exceed the assets and the firm becomes insolvent.
X5, Revenue/Total Assets (S/TA): The capital-turnover ratio is a standard financial ratio illustrating the sales generating ability of the firm's assets.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Patrangsit Healthcare Group PCL Altman Z-Score Chart
BKK:PHG vs HCA, THC, DVA: Altman Z-Score Comparison
For the Medical Care Facilities subindustry, Patrangsit Healthcare Group PCL's Altman Z-Score, along with its competitors' market caps and Altman Z-Score data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Patrangsit Healthcare Group PCL Altman Z-Score vs Healthcare Providers & Services Industry
For the Healthcare Providers & Services industry and Healthcare sector, Patrangsit Healthcare Group PCL's Altman Z-Score distribution charts can be found below:
* The bar in red indicates where Patrangsit Healthcare Group PCL's Altman Z-Score falls into.
Patrangsit Healthcare Group PCL Altman Z-Score Calculation
Altman Z-Score model is an accurate forecaster of failure up to two years prior to distress. It can be considered the assessment of the distress of industrial corporations.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency. GuruFocus does not calculate Altman Z-Score when X4 or X5 value is 0.
Patrangsit Healthcare Group PCL (BKK:PHG) has a Altman Z-Score of 6.62 as of Jul. 16, 2026. The Altman Z-score measures a company's bankruptcy risk. View historical data on Patrangsit Healthcare Group PCL and its competitors. This is 27% below median its historical median of 9.09. Over the past decade, Patrangsit Healthcare Group PCL's Altman Z-Score has ranged from 6.62 to 10.92. According to the industry distribution chart, Patrangsit Healthcare Group PCL ranks #117 out of 659 companies in the Healthcare Providers & Services industry, placing it in the top 17.8%.
Is Patrangsit Healthcare Group PCL's Altman Z-Score too high?
Patrangsit Healthcare Group PCL's current Altman Z-Score of 6.62 is 27% below median its 10-year median of 9.09. Over the past 10 years, this metric has ranged from a low of 6.62 to a high of 10.92. The Healthcare Providers & Services industry median Altman Z-Score is 2.45. Patrangsit Healthcare Group PCL's value of 6.62 is 170.2% above this industry median. Based on the distribution chart, Patrangsit Healthcare Group PCL ranks #117 out of 659 companies in the Healthcare Providers & Services industry, which is in the top quartile — a strong position relative to peers. Overall, Patrangsit Healthcare Group PCL has a GF Score™ of 43/100 and is considered Significantly Undervalued, reflecting its overall financial health beyond just this single metric.
How does Patrangsit Healthcare Group PCL's Altman Z-Score compare to HCA and THC?
According to the Healthcare Providers & Services industry distribution chart, Patrangsit Healthcare Group PCL ranks #117 out of 659 companies for Altman Z-Score. This places Patrangsit Healthcare Group PCL in the top 18% of its industry — outperforming the majority of peers. The industry median Altman Z-Score is 2.45. Patrangsit Healthcare Group PCL's value of 6.62 is 170.2% above this benchmark. Historically, Patrangsit Healthcare Group PCL's own Altman Z-Score has ranged from 6.62 to 10.92 over the past decade. While the company's 10-year median is 9.09 vs. the industry median of 2.45, Patrangsit Healthcare Group PCL has consistently been above the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Altman Z-Score for a Healthcare Providers & Services company?
The median Altman Z-Score among Healthcare Providers & Services companies is 2.45, based on 659 companies in the industry. Companies in the top quartile (top 25%) have a Altman Z-Score significantly above this median, while those in the bottom quartile fall well below. However, Altman Z-Score should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Patrangsit Healthcare Group PCL's current Altman Z-Score of 6.62 is 170.2% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Altman Z-Score mean?
A high Altman Z-Score can signal that a stock is expensive relative to its fundamentals. The Altman Z-score measures a company's bankruptcy risk. View historical data on Patrangsit Healthcare Group PCL and its competitors. For the Healthcare Providers & Services industry, the median Altman Z-Score is 2.45 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Patrangsit Healthcare Group PCL's current Altman Z-Score is 6.62, which is 27% below median its own 10-year median of 9.09. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Patrangsit Healthcare Group PCL stock overvalued right now?
Based on GuruFocus' analysis, Patrangsit Healthcare Group PCL (BKK:PHG) is currently considered Significantly Undervalued. The stock's GF Value™ is ฿15.89, compared to a current price of ฿10.30 — trading 35.2% below its estimated fair value. The current Altman Z-Score is 6.62, which is 27% below median its 10-year median of 9.09 and 170.2% above the Healthcare Providers & Services industry median of 2.45. Patrangsit Healthcare Group PCL's overall GF Score™ is 43/100. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Altman Z-Score calculated?
Altman Z-Score is calculated from a company's financial statements. For Patrangsit Healthcare Group PCL (BKK:PHG), the current Altman Z-Score is 6.62 as of Jul. 16, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Patrangsit Healthcare Group PCL (BKK:PHG) Overvalued in 2026?
Based on GuruFocus' analysis, Patrangsit Healthcare Group PCL stock appears to be undervalued.
The current stock price of ฿10.30 is trading 35.2% below its estimated GF Value™ of ฿15.89.
GuruFocus considers Patrangsit Healthcare Group PCL to be Significantly Undervalued.
Key valuation signals for BKK:PHG:
Altman Z-Score: 6.62 (27% below median its 10-year median of 9.09)
GF Value™: ฿15.89 vs. price of ฿10.30 (35.2% below fair value)
Industry Position: 170.2% above the Healthcare Providers & Services median (#117 of 659)
No single metric tells the full story. See the BKK:PHG stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Patrangsit Healthcare Group PCL Business Description
Patrangsit Healthcare Group PCL engages in the operations of the hospital business. The company's services include medical services, wardroom, health insurance customer services, corporate customer services and international services. It operates in one main reportable operating segment, which is hospital business and operates in one geographical area, which is Thailand.
43GF Score
Get the complete analysis for BKK:PHG
Altman Z-Score is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
BKK:PHG has been successfully added to your 
